Skip to content
← Back to this collection

PUBLICATIONS · 11267980

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Int J Cancer
Publication date
2001 Mar 1
First author
Plantaz D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Plantaz D
      type
      Author
    2. name
      Vandesompele J
      type
      Author
    3. name
      Van Roy N
      type
      Author
    4. name
      Lastowska M
      type
      Author
    5. name
      Bown N
      type
      Author
    6. name
      Combaret V
      type
      Author
    7. name
      Favrot MC
      type
      Author
    8. name
      Delattre O
      type
      Author
    9. name
      Michon J
      type
      Author
    10. name
      Bénard J
      type
      Author
    11. name
      Hartmann O
      type
      Author
    12. name
      Nicholson JC
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Plantaz D
      type
      Author
    2. name
      Vandesompele J
      type
      Author
    3. name
      Van Roy N
      type
      Author
    4. name
      Lastowska M
      type
      Author
    5. name
      Bown N
      type
      Author
    6. name
      Combaret V
      type
      Author
    7. name
      Favrot MC
      type
      Author
    8. name
      Delattre O
      type
      Author
    9. name
      Michon J
      type
      Author
    10. name
      Bénard J
      type
      Author
    11. name
      Hartmann O
      type
      Author
    12. name
      Nicholson JC
      type
      Author
    bibliography ids
    1. nci-bib-db9c7d5d64b4043becbb3467
    book metadata
    content sha256
    03f4e30afc0c704d2682e34387120a926032cf0aa1e88b9bd3434f12f5263b9e
    document type
    citation
    dois
    1. 10.1002/1097-0215(200002)9999:9999<::aid-ijc1114>3.0.co;2-r
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11267980
    immutable id
    pubmed:11267980@03f4e30afc0c704d2682e34387120a926032cf0aa1e88b9bd3434f12f5263b9e
    journal
    abbreviation
    Int J Cancer
    issn electronic
    Source null
    issn print
    0020-7136
    issue
    5
    name
    International journal of cancer
    nlm unique id
    0042124
    pages
    680-6
    volume
    91
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11267980
      provenance
      batch id
      30d2cd7affbbb92b6784
      provider
      NCBI PubMed ESummary
      record sha256
      7c50eb989b100db65242318d79e3429f522541ec2877a9892a42c23c6a8a110c
      response sha256
      ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
      retrieved at
      2026-09-09T23:45:39.779418+00:00
      publication date
      display
      2001 Mar 1
      precision
      day
      year
      2001
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11267980/
      title
      Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.

      Preserved source evidence · Independent clinical review pending · Not medical advice